BRCA1 and cancer: For example, tumors with increased DNA repair deficiency associated with a BRCA1/2 mutant and/or a homologous recombination-deficient (HRD) molecular profile are associated with higher mutation rates, whereas homologous recombination-proficient (HRP) cancer profiles are associated with stable DNA repair and lower mutation rate.